Destiny Of Elderly Patients With Lymphoma Indicated For Autologous Stem Cell Transplantation (Asct)

Background. Autologous stem cell transplantation is the standard method of treatment of relapsed/refractory lymphoma patients (pts) and is a part of first-line therapy in certain diagnoses. ASCT in elderly pts (≥60 years) is much less studied than in younger ones and usually, only pts who actually undergone ASCT are included. This is a retrospective analysis of all subsequent patients ≥60 years indicated for ASCT at 1st Department of Medicine, General University Hospital, Prague, during 2008-2016.